Clinical Trial Update: Dexmedetomidine and Propofol for Pediatric MRI Sedation [Phase 4]

View source ↗

Summary

Phase 4 trial assessing Dexmedetomidine and Propofol for pediatric MRI sedation has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Neoplasm
• Headache
• Hydrocephalus
• Neurofibromatoses
• Seizure Disorder
• Spine Deformity
• Tumor

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• PROPOFOL (Propofol)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Headache, Tumor | Phase 4 | Status: COMPLETED | Results posted: 2020-02-21